Highbridge Capital Management
TDAC icon

Highbridge Capital Management’s Translational Development Acquisition Corp TDAC Stock Holding History

Highbridge Capital Management’s Portfolio TDAC Stock Details TDAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.21M Buy
861,837
+823,198
+2,130% +$8.79M 0.22% 99
2026
Q1 		$408K Buy
+38,639
New +$407K 0.01% 165

Other funds holding TDAC

Linden Advisors
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
Kryger Capital
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return
Meteora Capital
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
LMR Partners
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Alberta Investment Management Corp (AIMCo)
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 21.9% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Highbridge Capital Management's TDAC Position: Q2 2026 in Review

Highbridge Capital Management increased its Translational Development Acquisition Corp (TDAC) stake by 2,130% in Q2 2026, buying an estimated $8.79M and bringing the position to 861,837 shares worth $9.21M. The position accounts for 0.22% of the portfolio, ranked #99.

Highbridge Capital Management first reported a position in TDAC in Q1 2026 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Highbridge Capital Management held 861,837 shares of Translational Development Acquisition Corp worth $9.21M as of Q2 2026.
  • Highbridge Capital Management bought 823,198 Translational Development Acquisition Corp shares in Q2 2026, an estimated $8.79M.
  • Translational Development Acquisition Corp made up 0.22% of Highbridge Capital Management's portfolio in Q2 2026, its #99 holding.
  • Highbridge Capital Management first reported a position in Translational Development Acquisition Corp in Q1 2026 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Highbridge Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.